✦ LIBER ✦

PCN39 EXPLORATORY COST EFFECTIVENESS ANALYSIS OF BEVACIZUMAB IN ADDITION TO FOLFOX-4 IN THE ADJUVANT TREATMENT OF STAGE III COLON CANCER: A UK PERSPECTIVE

✍ Scribed by P Ducournau; N Latimer; E Sabate; S Walzer

Book ID: 119597426
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 92 KB
Volume: 11
Category: Article
ISSN: 1098-3015
DOI: 10.1016/s1098-3015(10)66575-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN93 COST-MINIMIZATION ANALYSIS OF XELO

PCN93 COST-MINIMIZATION ANALYSIS OF XELOX (CAPECITABINE + OXALIPLATIN) VERSUS FOLFOX-4 (5-FU/LV + OXALIPLATIN) AS ADJUVANT TREATMENT IN STAGE III COLON CANCER UNDER THE BRAZILIAN PRIVATE PAYER PERSPECTIVE

✍ G Prolla; LG Borges; E Santos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

631 POSTER Cost-effectiveness analysis o

631 POSTER Cost-effectiveness analysis of oxaliplatin/5-FU/LV in adjuvant treatment of stage III colon cancer in the UK

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 144 KB

CN1 COST-EFFECTIVENESS ANALYSIS OF OXALI

CN1 COST-EFFECTIVENESS ANALYSIS OF OXALIPLATIN/5-FU/LV IN ADJUVANT TREATMENT OF STAGE III COLON CANCER IN THE UK AND GERMANY

✍ S Aballea; J Chancellor; M Raikou; M Drummond; R Diel; M Frick; S Rosenfeld; A B 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 56 KB

PCN26 A COST-EFFECTIVENESS ANALYSIS OF X

PCN26 A COST-EFFECTIVENESS ANALYSIS OF XELOX AND FOLFOX-4 COMBINED WITH OR WITHOUT BEVACIZUMAB FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER IN SPAIN

✍ J Darba; G Restovic; A Ramírez de Arellano 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 71 KB

6010 A three-arm phase III randomized tr

6010 A three-arm phase III randomized trial of FOLFOX-4 vs. FOLFOX-4 plus bevacizumab vs. XELOX plus bevacizumab in the adjuvant treatment of patients with stage III or high-risk stage II colon cancer: results of the interim safety analysis of the AVANT trial

✍ Hoff, P.; Clarke, S.; Cunningham, D.; Van Cutsem, E.; Moore, M.; Schmoll, H.J.; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 48 KB

Cost-effectiveness analysis of oxaliplat

Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US

✍ Samuel Aballéa; Jeremy V.M. Chancellor; Maria Raikou; Michael F. Drummond; Milto 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB 👁 2 views